Raporty Spółek ESPI/EBI

Commencing Sales of CompuFlo® Instruments / CathCheck™ Verification System Disposables within the UTMB Health Clear Lake Campus Hospital

MILESTONE MEDICAL (USU6005B1045)

07-07-2021 15:47:49 | Bieżący | ESPI | 14/2021
oRB_ASO: Commencing Sales of CompuFlo® Instruments / CathCheck™ Verification System Disposables within the UTMB Health Clear Lake Campus Hospital

PAP
Data: 2021-07-07

Firma: MILESTONE MEDICAL INC

oSpis tresci:
1. RAPORT BIEŻĄCY
2. MESSAGE (ENGLISH VERSION)
3. INFORMACJE O PODMIOCIE
4. PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ

Nazwa arkusza: RAPORT BIEŻĄCY


KOMISJA NADZORU FINANSOWEGO
Raport bieżący nr 14 / 2021
Data sporządzenia: 2021-07-07
Skrócona nazwa emitenta
MILESTONE MEDICAL
Temat
Commencing Sales of CompuFlo® Instruments / CathCheck™ Verification System Disposables within the UTMB Health Clear Lake Campus Hospital
Podstawa prawna
Art. 17 ust. 1 MAR - informacje poufne.
Treść raportu:
The Board of Directors of Milestone Medical Inc. _WAR: MMD, “the Company", “the Issuer"_, today announced that the University of Texas Medical Branch _UTMB_ Health Clear Lake Campus Hospital has begun use of the CompuFlo Epidural Instrument. UTMB is an institution of the University of Texas System and agency of the State of Texas. UTMB is a major academic health sciences center of global influence, with medical, nursing, health professions and graduate biomedical schools; a world-renowned research enterprise; and a growing, comprehensive health system with hospitals on four campuses. As previously announced, the Company had begun selling CompuFlo disposables to the UTMB Health Galveston Campus Hospital.

The Board of Directors of the Company is very pleased to announce that UTMB Health has expanded its use of the CompuFlo Epidural Instrument, including its consumables to its Clear Lake Campus Hospital. The agreement represents second hospital within the UTMB Health network. This expansion follows successful use of the instrument and disposables at the Galveston Campus Hospital and is strong validation of the favorable response to Milestone Scientific’s technology by leading anesthesiologists. The Board of Directors of the Company believes that the new sales force initiatives are taking hold, and interest in the technology is growing.

Nazwa arkusza: MESSAGE (ENGLISH VERSION)


MESSAGE _ENGLISH VERSION_

Nazwa arkusza: INFORMACJE O PODMIOCIE


MILESTONE MEDICAL INC
_pełna nazwa emitenta_
MILESTONE MEDICAL
_skrócona nazwa emitenta_ _sektor wg. klasyfikacji GPW w W-wie_
NJ 07039 .
_kod pocztowy_ _miejscowość_
South Orange Avenue Livingston 220
_ulica_ _numer_
+11 973 535 2717 +11 973 535 2829
_telefon_ _fax_
_e-mail_ _www_
27-5484393
_NIP_ _REGON_

Nazwa arkusza: PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ


PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ
Data Imię i Nazwisko Stanowisko/Funkcja Podpis
2021-07-07 Arjan Haverhals Chief Executive Officer Arjan Haverhals


Identyfikator raportu g3rnkvrut1
Nazwa raportu RB_ASO
Symbol raportu RB_ASO
Nazwa emitenta MILESTONE MEDICAL INC
Symbol Emitenta MILESTONE MEDICAL
Tytul Commencing Sales of CompuFlo® Instruments / CathCheck™ Verification System Disposables within the UTMB Health Clear Lake Campus Hospital
Sektor
Kod NJ 07039
Miasto .
Ulica South Orange Avenue Livingston
Nr 220
Tel. +11 973 535 2717
Fax +11 973 535 2829
e-mail
NIP 27-5484393
REGON
Data sporzadzenia 2021-07-07
Rok biezacy 2021
Numer 14
adres www
Serwis Ekonomiczny Polskiej Agencji Prasowej SA 2021 Copyright PAP SA - Wszelkie prawa zastrzezone.